BIOMAT Database Logo BIOMAT Database Logo

Tuberculous pericarditis in a woman infected with human immunodeficiency virus type 1, long-term nonprogressive. 1997

E Buil, and C Manso, and F Vidal, and J Peraire, and C Richart

UI MeSH Term Description Entries
D007538 Isoniazid Antibacterial agent used primarily as a tuberculostatic. It remains the treatment of choice for tuberculosis. Isonicotinic Acid Hydrazide,Ftivazide,Isonex,Isonicotinic Acid Vanillylidenehydrazide,Phthivazid,Phthivazide,Tubazide,Acid Vanillylidenehydrazide, Isonicotinic,Hydrazide, Isonicotinic Acid,Vanillylidenehydrazide, Isonicotinic Acid
D010495 Pericarditis, Tuberculous INFLAMMATION of the sac surrounding the heart (PERICARDIUM) due to MYCOBACTERIUM TUBERCULOSIS infection. Pericarditis can lead to swelling (PERICARDIAL EFFUSION), compression of the heart (CARDIAC TAMPONADE), and preventing normal beating of the heart. Tuberculous Pericarditis,Pericarditides, Tuberculous,Tuberculous Pericarditides
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000995 Antitubercular Agents Drugs used in the treatment of tuberculosis. They are divided into two main classes: "first-line" agents, those with the greatest efficacy and acceptable degrees of toxicity used successfully in the great majority of cases; and "second-line" drugs used in drug-resistant cases or those in which some other patient-related condition has compromised the effectiveness of primary therapy. Anti-Tuberculosis Agent,Anti-Tuberculosis Agents,Anti-Tuberculosis Drug,Anti-Tuberculosis Drugs,Antitubercular Agent,Antitubercular Drug,Tuberculostatic Agent,Tuberculostatic Agents,Antitubercular Drugs,Agent, Anti-Tuberculosis,Agent, Antitubercular,Agent, Tuberculostatic,Anti Tuberculosis Agent,Anti Tuberculosis Agents,Anti Tuberculosis Drug,Anti Tuberculosis Drugs,Drug, Anti-Tuberculosis,Drug, Antitubercular
D017088 AIDS-Related Opportunistic Infections Opportunistic infections found in patients who test positive for human immunodeficiency virus (HIV). The most common include PNEUMOCYSTIS PNEUMONIA, Kaposi's sarcoma, cryptosporidiosis, herpes simplex, toxoplasmosis, cryptococcosis, and infections with Mycobacterium avium complex, Microsporidium, and Cytomegalovirus. HIV-Related Opportunistic Infections,Opportunistic Infections, AIDS-Related,Opportunistic Infections, HIV-Related,AIDS Related Opportunistic Infections,AIDS-Related Opportunistic Infection,HIV Related Opportunistic Infections,HIV-Related Opportunistic Infection,Infection, HIV-Related Opportunistic,Infections, HIV-Related Opportunistic,Opportunistic Infection, AIDS-Related,Opportunistic Infection, HIV-Related,Opportunistic Infections, AIDS Related,Opportunistic Infections, HIV Related
D018791 CD4 Lymphocyte Count The number of CD4-POSITIVE T-LYMPHOCYTES per unit volume of BLOOD. Determination requires the use of a fluorescence-activated flow cytometer. Lymphocyte Count, CD4,T4 Lymphocyte Count,CD4 Cell Counts,CD4 Counts,CD4+ Cell Counts,CD4+ Counts,CD4 Cell Count,CD4 Count,CD4 Lymphocyte Counts,CD4+ Cell Count,CD4+ Count,Count, T4 Lymphocyte,Counts, T4 Lymphocyte,Lymphocyte Count, T4,Lymphocyte Counts, CD4,Lymphocyte Counts, T4,T4 Lymphocyte Counts

Related Publications

E Buil, and C Manso, and F Vidal, and J Peraire, and C Richart
Long-term nonprogressive infection with human immunodeficiency virus type 1 in a hemophilia cohort.
December 1999, The Journal of infectious diseases,
E Buil, and C Manso, and F Vidal, and J Peraire, and C Richart
A balanced type 1/type 2 response is associated with long-term nonprogressive human immunodeficiency virus type 1 infection.
September 2002, Journal of virology,
E Buil, and C Manso, and F Vidal, and J Peraire, and C Richart
Long-term nonprogressive human immunodeficiency virus-1 infection in a kidney allograft recipient.
November 1998, Transplantation,
E Buil, and C Manso, and F Vidal, and J Peraire, and C Richart
Studies in subjects with long-term nonprogressive human immunodeficiency virus infection.
January 1995, The New England journal of medicine,
E Buil, and C Manso, and F Vidal, and J Peraire, and C Richart
High frequency of defective nef alleles in a long-term survivor with nonprogressive human immunodeficiency virus type 1 infection.
November 1996, Journal of virology,
E Buil, and C Manso, and F Vidal, and J Peraire, and C Richart
Neutralization escape in human immunodeficiency virus type 1-infected long-term nonprogressors.
May 1999, The Journal of infectious diseases,
E Buil, and C Manso, and F Vidal, and J Peraire, and C Richart
Neutralizing antibody responses to human immunodeficiency virus type 1 in primary infection and long-term-nonprogressive infection.
October 1997, The Journal of infectious diseases,
E Buil, and C Manso, and F Vidal, and J Peraire, and C Richart
Unusual polymorphisms in human immunodeficiency virus type 1 associated with nonprogressive infection.
May 2000, Journal of virology,
E Buil, and C Manso, and F Vidal, and J Peraire, and C Richart
[Bilateral tuberculous mastitis in a woman infected by the human immunodeficiency virus].
February 2000, Enfermedades infecciosas y microbiologia clinica,
E Buil, and C Manso, and F Vidal, and J Peraire, and C Richart
Defective accessory genes in a human immunodeficiency virus type 1-infected long-term survivor lacking recoverable virus.
July 1995, Journal of virology,
Copied contents to your clipboard!